BASF opens new GMP Solution Center in Michigan

BASF opens its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.
This new facility will play a crucial role in the expansion of BASF's existing network of GMP sites, with innovative systems and processes that ensure products are produced consistently and controlled according to high quality standards. These practices are crucial in the pharmaceutical industry, where the quality of products is paramount for safety and efficacy.
Featuring state-of-the-art clean room packaging, and high-sensitivity analytical testing, this new facility enables close collaboration with customers on customized chemistries for product development. Additionally, improved manufacturing capabilities will allow for more tightly controlled parameters beyond compendial limits and a validated control system that allows for high reproductivity.
Marion Kuhn, vice president of business management, BASF Pharma Solutions states, 'Our new GMP Solution Center exemplifies BASF's dedication to understanding and addressing the evolving needs of our customers in both the biopharma and pharmaceutical industries. This state-of-the-art facility will play a fundamental role in enabling us to collaborate closely with our customers worldwide on product development and GMP manufacturing in ways that are unique to the industry, further strengthening our position as an innovator in the pharmaceutical sector.'
'Wyandotte's new GMP Solution Center is a key example of BASF's commitment to innovative excellence,' said Benjamin Knudsen, vice president of research North America at BASF Corporation. 'This expansion not only showcases our dedication to developing customized solutions, but it also highlights our ability to adapt and innovate in response to our customers' needs. Together, we are paving the way for new innovative solutions.' Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged.
BASF has opened a new GMP Solution Center in Wyandotte, Michigan, enhancing its support for the biopharma and pharmaceutical industries. The facility features clean room packaging, advanced testing, and custom chemistry development. It strengthens BASF's global GMP network and commitment to high-quality, innovative solutions and close customer collaboration.
Fibre2Fashion News Desk (HU)

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Time of India

a day ago

• Time of India

HDB Financial's Rs 12,500 crore IPO: 10 key facts investors should know before June 25

Investor interest is building around the upcoming initial public offering of HDB Financial Services , the non-banking finance arm backed by HDFC Bank . At Rs 12,500 crore, the long-awaited issue is poised to be the largest of 2025 so far, drawing attention from both institutional players and retail participants. As the subscription window nears, here are 10 key facts investors should know. 1. GMP points to strong debut As of June 20, the grey market premium for HDB Financial stood at Rs 83, implying a listing price of Rs 823, an 11.22% premium to the issue's upper band. Market watchers note the GMP trend has been upward in recent sessions, signalling expectations of a firm listing. 2. The largest IPO of the year to date With a total issue size of Rs 12,500 crore, HDB Financial's IPO is set to be the biggest in 2025 so far. It also ranks as the largest public offering since Hyundai Motor India's Rs 27,000 crore IPO last year. 3. HDB Financial Services IPO price band The price band for the issue has been fixed at Rs 700 to Rs 740 per share. Investors are advised to consider bidding at the cut-off to improve allocation chances in the event of oversubscription. 4. Subscription window The IPO will open for subscription on Tuesday, June 25, and close on Thursday, June 27. The basis of allotment is expected to be finalised on Monday, June 30. 5. Tentative listing Shares of HDB Financial are expected to list on both the BSE and NSE on Wednesday, July 2, subject to final regulatory approvals. 6. Offer structure The IPO comprises a fresh issue of Rs 2,500 crore and an offer for sale worth Rs 10,000 crore by HDFC Bank, which currently holds a 94.6% stake in the company. The share sale forms part of the bank's broader capital optimisation strategy. 7. Quotas reserved The issue includes reserved portions for eligible employees of HDB Financial as well as shareholders of parent HDFC Bank . 8. Application sizes and investment requirements Retail investors can apply for a minimum of 20 shares, amounting to Rs 14,000 at the lower band and Rs 14,800 at the upper band. For small non-institutional investors applicants, the minimum investment is Rs 2,07,200 (14 lots); for big non-institutional investors, it is Rs 10,06,400 (68 lots). 9. Managed by a consortium of global and domestic banks The IPO is being led by a 13-member syndicate of book-running lead managers, including BofA Securities India, Goldman Sachs (India), Morgan Stanley, JM Financial , Motilal Oswal, and others. MUFG Intime India (Link Intime) is the registrar. 10. Key player in India's NBFC sector HDB Financial Services operates across retail and commercial lending segments, offering products such as personal loans, vehicle loans, gold loans, and loans against property. The company has a wide presence in semi-urban and rural markets, and intends to use the fresh issue proceeds to bolster capital adequacy and support lending growth. Also read | HDFC Bank shares in focus as Rs 12,500-crore HDB Financial IPO opens next week ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

Business Standard

a day ago

• Business Standard

Ellenbarrie sets IPO price at ₹380-400; Arisinfra subscribed 1.3x on Day 2

Ellenbarrie sets IPO price at ₹380 -400 Ellenbarrie Industrial Gases has priced its initial public offering (IPO) between ₹380-400 per share. The IPO will open on Tuesday and close on Thursday. The ₹852 crore IPO is a mix of fresh issue wo­rth ₹400 crore and an offer for sale of ₹452 crore. ALSO READ: Real estate giant Kalpataru eyes deleveraging amid ₹1,590 cr IPO Day 2: Arisinfra IPO subscribed 1.3 x The IPO of Arisinfra Solutions was subscribed 1.3 times on Thursday, the penultimate day of the issue. The institutional investor portion was subscribed 0.7 times, the wealthy investor portion by 1.4 times, and the retail investor portion by 3 times. ALSO READ: Influx Healthtech IPO Day 2 update: Subscription rises 16x, GMP at 47% Capillary Tech India files for IPO Capillary Technologies India, a company that offers artificial intelligence-based cloud-native SaaS products, refiled its draft red herring prospectus to raise funds for its initial public offering (IPO). The IPO comprises an issue of equity shares aggregating to ₹430 crore. ALSO READ: Oswal Pumps IPO listing forecast: Here's what the latest GMP hints at

India Today

2 days ago

• India Today

Oswal Pumps IPO listing: Will it make a bumper debut? Check latest GMP

Oswal Pumps is poised to make its stock market debut on June 20, amid strong anticipation from investors looking for a bumper debut on Dalal allotment for the initial public offering (IPO) of Oswal Pumps was finalised on June 18, 2025, after attracting substantial interest despite initial slow IPO of Oswal Pumps was oversubscribed by more than 34 times, indicating strong confidence from investors, especially among Qualified Institutional Buyers (QIBs) and Non-Institutional Investors (NIIs). This response underscores the institutional trust in the company's fundamental strength and its projected long-term growth prospects, even in the face of market The price band for the IPO was fixed between Rs 584 and Rs 614 per share. The minimum lot size was 24 shares. For retail investors, this meant a minimum investment of Rs 14,016 at the lower end of the price band. However, most retail investors prefer bidding at the cut-off price, which required an investment of Rs 14,736."We believe this overwhelming demand was driven by attractive valuation levels, offering reasonable long-term upside potential along with a well-diversified product portfolio across agriculture, industrial, and domestic water solutions. We also see the company's strategic positioning to benefit from ongoing government infrastructure and rural development initiatives, especially those focused on water management and irrigation," said Prashanth Tapse, Senior VP (Research) at Mehta Equities experts are optimistic about the listing, expecting a gain in the range of 10–15% based on current market sentiment and the strong subscription estimated listing price is Rs 662, factoring in the current Grey Market Premium (GMP). However, the GMP has seen a decline recently, falling from Rs 60 during allotment to Rs 48 as of June 19."Given the strong subscription demand and ongoing market sentiment, we anticipate a decent listing gain in the range of 10–15% for Oswal Pumps debut. The IPO saw significant oversubscription, reflecting confidence in the company's fundamentals and valuation. We view Oswal Pumps as a compelling long-term investment opportunity, well-aligned with the government's continued emphasis on rural electrification and promotion of solar-powered irrigation systems," added investors who have been allotted shares, holding onto the investment is advised due to the strong structural growth prospects in the agriculture and infrastructure sectors. The company is seen as well-positioned to benefit from sectoral growth drivers."For Allotted investors: We advise a HOLD for the long term, as the company is well-positioned to benefit from structural growth drivers in the agri and infrastructure sectors. For Non-allotted investors: Consider accumulating on any dips post-listing, particularly if broader market sentiment causes short-term volatility. The business offers a strong combination of sectoral tailwinds and value-based fundamentals," he advised will be keenly watching the debut, hoping for a favourable outcome that aligns with the optimistic projections.